Insulin–Insulin-Like Growth Factor Axis and Colon Cancer
- 10 January 2009
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (2) , 165-167
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803Journal of Clinical Oncology, 2008
- Insulin in the Adjuvant Breast Cancer Setting: A Novel Therapeutic Target for Lifestyle and Pharmacologic Interventions?Journal of Clinical Oncology, 2008
- Insulin-Like Growth Factor-Related Signaling and Cancer Development2007
- Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon CancerJNCI: Journal of the National Cancer Institute, 2006
- Adjuvant Diet to Improve Hormonal and Metabolic Factors Affecting Breast Cancer PrognosisAnnals of the New York Academy of Sciences, 2006
- Insulin Resistance, Apoptosis, and Colorectal Adenoma RiskCancer Epidemiology, Biomarkers & Prevention, 2005
- Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal CancerJNCI: Journal of the National Cancer Institute, 2002
- Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort StudyJournal of Clinical Oncology, 2002
- Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3JNCI: Journal of the National Cancer Institute, 1999
- Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loopInternational Journal of Cancer, 1994